BCR/ABL and Other Kinases from Chronic Myeloproliferative Disorders Stimulate Single-Strand Annealing, an Unfaithful DNA Double-Strand Break RepairKimberly Cramer, Tomasz Skórski|Cancer Research|2008Cited by 95
Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasmsMargaret Nieborowska-Skorska, Tomasz Skórski|Blood|2017Cited by 77
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cellsMargaret Nieborowska-Skorska, Tomasz Skórski|Journal of Clinical Investigation|2017Cited by 75
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow MicroenvironmentBac Viet Le, Tomasz Skórski|Cell Reports|2020Cited by 29
Simultaneous Inhibition of BCR-ABL1 Tyrosine Kinase and PAK1/2 Serine/Threonine Kinase Exerts Synergistic Effect against Chronic Myeloid Leukemia CellsSylwia Flis, Tomasz Skórski|Cancers|2019Cited by 21